BioAegis Therapeutics Raises $3M
Biopharma startup BioAegis Therapeutics has raised $3 million in new funding. The company did not disclose details of the round, but said the money will be used for continued development of its products focused on the repletion of human plasma gelsolin.
8 February 2013•2 mins read
